Full Year 2022 Results


2022 Preliminary Results

Uniphar PLC 2022 Preliminary Results

2022 Preliminary Results Presentation

Uniphar 2022 FY Results Presentation

FY 2022 Key Stats

€98.0m
EBITDA
5.7%
Organic GP Growth YoY
17.3%
ROCE
18.4c
Adjusted EPS

Group Highlights

€306.7m

2022 GP

Employees
Partnering with 7 of the top 10 pharma companies
and 7 of the top 10 medical device companies